Turajlic S et al.Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition.Ann Oncol 25:959-67 (2014).
Girotti MR et al.Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma.Cancer Discov 3:158-67 (2013).
Zirakzadeh AA et al.Multiplex B cell characterization in blood, lymph nodes, and tumors from patients with malignancies.J Immunol 190:5847-55 (2013).
Lee SJ et al.Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis.Autophagy 7:829-39 (2011).
VanBrocklin MW et al.Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice.Pigment Cell Melanoma Res 23:531-41 (2010).
Azarova AM et al.Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.Proc Natl Acad Sci U S A 104:11014-9 (2007).
Yamazaki F et al.Development of a new mouse model (xeroderma pigmentosum a-deficient, stem cell factor-transgenic) of ultraviolet B-induced melanoma.J Invest Dermatol 125:521-5 (2005).
Jungbluth AA et al.A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.Am J Surg Pathol 22:595-602 (1998).
Beaty MW et al.Effusion cytology of malignant melanoma. A morphologic and immunocytochemical analysis including application of the MART-1 antibody.Cancer 81:57-63 (1997).